Bringing the power of DNA testing to everyone.

Spartan /'sparten/ adj. & n. • adj. 1 of or relating to Sparta in ancient Greece. 2 possessing the qualities of courage, endurance, stern frugality, etc, associated with Sparta.

Spartan is a leading biotechnology company that has developed DNA analyzer the size of a coffee cup. Spartan's RX technology is cleared by the FDA and used by expert organizations such as the CDC and Mayo Clinic. Spartan's mission is making affordable products, in fields as diverse as infectious disease, precision medicine, and water safety testing.

Medical Need

In the same way that mainframe computers gave way to personal computers, high-throughput DNA testing systems in central labs are giving way to decentralized devices. Stop waiting days to weeks—get rapid results with Spartan.

Environmental Need

Bacterial culture testing with Petri dishes is technology that is 150 years old. Medical diagnostics has replaced it with fast and accurate qPCR technology. Now this trend is coming to environmental water testing. Spartan has developed the first on-site Legionella qPCR test and it enables early detection and decontamination of building water systems.

Bringing the Spartan technology to other industries

Bringing our core patented DNA technology into the hands of everyone means being open to innovation. We believe our products will rise to meet to diagnosis and detection needs beyond the clinical and environmental space.

Spartan's technology is backed by:

2 million hours of R&D

9 patents issued, 6 pending

16 peer-reviewed scientific publications

ISO 12869 validation and ISO 13485 certification

Strong group of molecular biologists and engineers


Patrick J. Mallon

Patrick J. Mallon

Executive Director

Pat has extensive experience in the bio/pharmaceutical, medical device and life sciences industries and a successful track record in building both start-up and Fortune 500 companies. He was integral in the development and commercialization of PCR technology and introduction of the world’s first protease inhibitor for HIV disease. He is a biotechnology industry leader having held leadership roles at Pfizer (NYSE: PFE), Roche (SWX: RO), and Hologic (NASDAQ: HOLX).

Paul Lem

Paul Lem, M.D.

Founder & Chief Medical Officer

As Spartan's Chief Medical Officer, Paul is responsible for the development and implementation of the company's clinical and environmental testing strategies. Paul co-founded Spartan with John Lem and Dr. Jamie Spiegelman in 2005.

Prior to Spartan, Paul served as Vice President, Product Management at DNA Genotek (acquired by Orasure Technologies). He co-invented the Oragene DNA self-collection kit that is used by millions of people around the world through companies such as 23andMe and He was also founder and CEO of Plexagen.

Paul holds a bachelor's degree in human biology from the University of Toronto, and a medical degree from the University of Ottawa. He graduated from the inaugural class of Singularity University. In 2010, Paul was honored with the $200K Premier's Catalyst Award for Best Young Innovator.

Sean Tomalty

Sean Tomalty

Chief Operating Officer

Sean joined Spartan in 2015, and is responsible for the manufacturing of Spartan's instruments and tests.

Sean has more than 30 years of experience in operations and manufacturing at companies including Abbott Point of Care, JDSU, and Nortel. At Abbott, he was Plant Director of a 500,000 square-foot medical device manufacturing facility that produced the i-STAT® portable clinical analyzer and 35 million test cartridges annually.

Sean holds a Bachelor of Mechanical Engineering degree from Carleton University and a Masters of Business Administration degree from Queen's University. He is a licensed Professional Engineer.

Paul Markell

Paul Markell

Chief Administrative Officer

Paul joined Spartan in 2007 and he oversees day-to-day operations and quality assurance.

Paul has over 30 years of experience with startups and multinational companies, including chief operating officer at Sciemetric Instruments, and director of finance and operations at Gandalf, a division of Mitel.

Paul holds a bachelor's degree in genetics from the University of Guelph.

Steve Edgett

Steve Edgett

Executive Vice President

Steve joined Spartan in 2019 and oversees corporate strategy and international business development.

Steve has more than 15 years of experience in business development, strategic planning, and international markets such as the Middle East. He has founded and held senior leadership roles in several high-technology companies, including Knowmadics, Cobham plc, and EMS Technologies (NASDAQ: ELMG). Most recently, Steve was the CEO and President of Nautics Group, a military surveillance company.

Steve holds an honor's bachelor of applied science in systems design engineering from the University of Waterloo.